Gregory Botta • UCSD Profiles (original) (raw)
- Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Therapy. Cancers (Basel). 2026 Feb 11; 18(4). Chakrabarti S, Cohen SA, Tin A, Dangl A, Chung KY, Tejani MA, Fakih MG, Chandana SR, Donahue CA, George V, Malla M, Aushev VN, George GV, Ortiz JB, Herter WK, Nagarajan A, Weinberg BA, Sharma VR, Botta GP, Cho M, Azzi G, Kasi A, Dayyani F, Hanna DL, Somer BG, Malhotra M, Sharma S, Jurdi A, Liu MC, Landmann RG, Dasari A. PMID: 41749842; PMCID: PMC12938644.
View in: PubMed Mentions: - Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group. JCO Precis Oncol. 2025 Mar; 9:e2400489. Rajdev L, King GG, Lieu CH, Cohen SA, Pant S, Uboha NV, Deming D, Malla M, Kasi A, Klute K, Spencer KR, Dasari A, Morris VK, Botta G, Lowy AM, O'Hara MH, Eads J, King D, Shah MA, Hong TS, Parikh A, Klempner SJ, Jabbour SK, Chawla A, Molena D, George TJ, Gibson MK, Allegra C, Goodman K, Eng C, Philip PA. PMID: 40048671; PMCID: PMC11893001.
View in: PubMed Mentions: 1 Fields:
Translation:Humans - Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations. J Clin Oncol. 2025 Feb 20; 43(6):705-715. Weitz J, Nishizaki D, Liau J, Patel J, Ng I, Sun S, Ramms D, Zou J, Wishart B, Rull J, Baumgartner J, Kelly K, White R, Veerapong J, Hosseini M, Patel H, Botta G, Gutkind JS, Tiriac H, Kato S, Lowy AM. PMID: 39413348; PMCID: PMC11829827.
View in: PubMed Mentions: 4 Fields:
Translation:Humans - Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma. Oncologist. 2024 Oct 03; 29(10):859-869. Botta GP, Abdelrahim M, Drengler RL, Aushev VN, Esmail A, Laliotis G, Brewer CM, George GV, Abbate SM, Chandana SR, Tejani MA, Malla M, Bansal D, Rivero-Hinojosa S, Spickard E, McCormick N, Cecchini M, Lacy J, Fei N, Kasi PM, Kasi A, Dayyani F, Hanna DL, Sharma S, Malhotra M, Aleshin A, Liu MC, Jurdi A. PMID: 39022993; PMCID: PMC11449101.
View in: PubMed Mentions: 18 Fields:
Translation:Humans - Viewing the immune checkpoint VISTA: landscape and outcomes across cancers. ESMO Open. 2024 Apr; 9(4):102942. Nishizaki D, Kurzrock R, Miyashita H, Adashek JJ, Lee S, Nikanjam M, Eskander RN, Patel H, Botta GP, Nesline MK, Pabla S, Conroy JM, DePietro P, Sicklick JK, Kato S. PMID: 38503143; PMCID: PMC10966162.
View in: PubMed Mentions: 17 Translation:Humans - Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status. ESMO Gastrointest Oncol. 2024 Jun; 4:100042. Faber EB, Baca Y, Xiu J, Walker P, Manji G, Gholami S, Saeed A, Prakash A, Botta GP, Sohal D, Lenz HJ, Shields AF, Nabhan C, El-Deiry W, Seeber A, Chiu V, Hwang J, Lou E. PMID: 41648036; PMCID: PMC12836609.
View in: PubMed Mentions: - Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells. J Immunother Cancer. 2024 02 05; 12(2). Botta GP, Chao J, Ma H, Hahn M, Sierra G, Jia J, Hendrix AY, Nolte Fong JV, Ween A, Vu P, Miller A, Choi M, Heyman B, Daniels GA, Kaufman D, Jamieson C, Li Z, Cohen E. PMID: 38316518; PMCID: PMC10860094.
View in: PubMed Mentions: 17 Fields:
Translation:HumansCells - Challenges and prospects of CSF1R targeting for advanced malignancies. Am J Cancer Res. 2023; 13(7):3257-3265. Moeller A, Kurzrock R, Botta GP, Adashek JJ, Patel H, Lee S, Pabla S, Nesline MK, Conroy J, Sicklick JK, Kato S. PMID: 37560003; PMCID: PMC10408490.
View in: PubMed Mentions: 10 - Role of Circulating Tumor DNA Among Patients with Colorectal Peritoneal Metastases. J Gastrointest Cancer. 2024 Mar; 55(1):41-46. Baumgartner JM, Botta GP. PMID: 37436640; PMCID: PMC11096195.
View in: PubMed Mentions: 6 Fields:
Translation:Humans - Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma. Oncologist. 2023 03 17; 28(3):220-229. Azzi G, Tavallai M, Aushev VN, Koyen Malashevich A, Botta GP, Tejani MA, Hanna D, Krinshpun S, Malhotra M, Jurdi A, Aleshin A, Kasi PM. PMID: 36562592; PMCID: PMC10020810.
View in: PubMed Mentions: 7 Fields:
Translation:Humans - Personalized matched targeted therapy in advanced pancreatic cancer: a pilot cohort analysis. NPJ Genom Med. 2023 Jan 20; 8(1):1. Shaya J, Kato S, Adashek JJ, Patel H, Fanta PT, Botta GP, Sicklick JK, Kurzrock R. PMID: 36670111; PMCID: PMC9860045.
View in: PubMed Mentions: 19 - Neoadjuvant chemotherapy and radiotherapy outcomes in borderline-resectable and locally-advanced pancreatic cancer patients. Cancer Med. 2023 04; 12(7):7713-7723. Botta GP, Huynh TR, Spierling-Bagsic SR, Agelidis A, Schaffer R, Lin R, Sigal D. PMID: 36478411; PMCID: PMC10134275.
View in: PubMed Mentions: 4 Fields:
Translation:Humans - Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers. JCO Precis Oncol. 2022 12; 6:e2200420. Huffman BM, Aushev VN, Budde GL, Chao J, Dayyani F, Hanna D, Botta GP, Catenacci DVT, Maron SB, Krinshpun S, Sharma S, George GV, Malhotra M, Jurdi A, Moshkevich S, Aleshin A, Kasi PM, Klempner SJ. PMID: 36480779; PMCID: PMC10530958.
View in: PubMed Mentions: 38 Fields:
Translation:Humans - Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy. NPJ Precis Oncol. 2022 Sep 22; 6(1):67. Louie BH, Kato S, Kim KH, Lim HJ, Okamura R, Eskander RN, Botta G, Patel H, Lee S, Lippman SM, Sicklick JK, Kurzrock R. PMID: 36138116; PMCID: PMC9500013.
View in: PubMed Mentions: 6 - SMARCA4: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy. Mol Cancer Ther. 2021 12; 20(12):2341-2351. Mardinian K, Adashek JJ, Botta GP, Kato S, Kurzrock R. PMID: 34642211; PMCID: PMC8643328.
View in: PubMed Mentions: 99 Fields:
Translation:HumansCells - SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer. JCI Insight. 2021 09 22; 6(18). Botta GP, Kato S, Patel H, Fanta P, Lee S, Okamura R, Kurzrock R. PMID: 34375311; PMCID: PMC8492298.
View in: PubMed Mentions: 41 Fields:
Translation:Humans - Tri-modal management of primary small cell carcinoma of the pancreas (SCCP): a rare neuroendocrine carcinoma (NEC). BMC Gastroenterol. 2021 Sep 03; 21(1):340. Elzein S, Bao F, Lin R, Schnickel G, Lowy AM, Botta GP. PMID: 34479480; PMCID: PMC8414857.
View in: PubMed Mentions: 4 Fields:
Translation:Humans - Tumor-penetrating therapy for β5 integrin-rich pancreas cancer. Nat Commun. 2021 03 09; 12(1):1541. Hurtado de Mendoza T, Mose ES, Botta GP, Braun GB, Kotamraju VR, French RP, Suzuki K, Miyamura N, Teesalu T, Ruoslahti E, Lowy AM, Sugahara KN. PMID: 33750829; PMCID: PMC7943581.
View in: PubMed Mentions: 42 Fields:
Translation:HumansAnimalsCells - Hemorrhagic Cystitis: Treatment With Hyperbaric Oxygen Therapy in Patients With Acute Lymphoblastic Leukemia. Clin J Oncol Nurs. 2018 12 01; 22(6):E146-E151. Botta LM, Botta GP. PMID: 30451996.
View in: PubMed Mentions: 2 Fields:
Translation:Humans - Reversible intrahepatic cholestasis in metastatic prostate cancer: An uncommon paraneoplastic syndrome. Mol Clin Oncol. 2018 04; 8(4):609-612. Bhangoo MS, Cheng B, Botta GP, Thorson P, Kosty MP. PMID: 29541472; PMCID: PMC5838296.
View in: PubMed Mentions: 12 - Advances on immunotherapy in genitourinary and renal cell carcinoma. Transl Cancer Res. 2017 Feb; 6(1):17-29. Botta GP, Granowicz E, Costantini C. PMID: 28966917; PMCID: PMC5617347.
View in: PubMed Mentions: 7 - Spontaneous Iliopsoas Muscle Hemorrhage Secondary to Ibrutinib (Imbruvica; Pharmacyclics): Brief Report. J Investig Med High Impact Case Rep. 2016 Apr-Jun; 4(2):2324709616648457. Sarcon A, Botta GP, Patel N, Saven A. PMID: 27231694; PMCID: PMC4871198.
View in: PubMed Mentions: Fields: - Isolation, culture and genetic manipulation of mouse pancreatic ductal cells. Nat Protoc. 2013; 8(7):1354-65. Reichert M, Takano S, Heeg S, Bakir B, Botta GP, Rustgi AK. PMID: 23787893; PMCID: PMC4121532.
View in: PubMed Mentions: 63 Fields:
Translation:AnimalsCells - ERK2-regulated TIMP1 induces hyperproliferation of K-Ras(G12D)-transformed pancreatic ductal cells. Neoplasia. 2013 Apr; 15(4):359-72. Botta GP, Reichert M, Reginato MJ, Heeg S, Rustgi AK, Lelkes PI. PMID: 23555182; PMCID: PMC3612909.
View in: PubMed Mentions: 12 Fields:
Translation:HumansAnimalsCells - Electrospun hydroxyapatite-containing chitosan nanofibers crosslinked with genipin for bone tissue engineering. Biomaterials. 2012 Dec; 33(36):9167-78. Frohbergh ME, Katsman A, Botta GP, Lazarovici P, Schauer CL, Wegst UG, Lelkes PI. PMID: 23022346; PMCID: PMC3488354.
View in: PubMed Mentions: 93 Fields:
Translation:AnimalsCells - Constitutive K-RasG12D activation of ERK2 specifically regulates 3D invasion of human pancreatic cancer cells via MMP-1. Mol Cancer Res. 2012 Feb; 10(2):183-96. Botta GP, Reginato MJ, Reichert M, Rustgi AK, Lelkes PI. PMID: 22160930; PMCID: PMC3288768.
View in: PubMed Mentions: 30 Fields:
Translation:HumansCells - Sex of muscle stem cells does not influence potency for cardiac cell therapy. Cell Transplant. 2009; 18(10):1137-46. Drowley L, Okada M, Payne TR, Botta GP, Oshima H, Keller BB, Tobita K, Huard J. PMID: 19523348.
View in: PubMed Mentions: 5 Fields:
Translation:Animals - Real-time assessment of three-dimensional cell aggregation in rotating wall vessel bioreactors in vitro. Nat Protoc. 2006; 1(4):2116-27. Botta GP, Manley P, Miller S, Lelkes PI. PMID: 17487203.
View in: PubMed Mentions: 8 Fields:
Translation:HumansAnimalsCells
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
Start with: newest oldestInclude: line numbers double spacing all authors publication IDs